tetramethylpyrazine has been researched along with Dementia, Vascular in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fu, Y; Liu, X; Sun, H; Zhao, T | 1 |
Deng, S; Li, H; Qin, DL; Zhang, Z; Zhou, M | 1 |
2 other study(ies) available for tetramethylpyrazine and Dementia, Vascular
Article | Year |
---|---|
Ligustrazine suppresses neuron apoptosis via the Bax/Bcl-2 and caspase-3 pathway in PC12 cells and in rats with vascular dementia.
Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Brain-Derived Neurotrophic Factor; Carotid Artery, Common; Caspase 3; Cell Hypoxia; Cell Survival; Cerebrovascular Disorders; Chemokine CCL2; Dementia, Vascular; Gene Expression Regulation; Glucose; Homocysteine; Ligusticum; Male; Mitochondria; Neurons; Neuroprotective Agents; PC12 Cells; Plant Extracts; Proto-Oncogene Proteins c-bcl-2; Pyrazines; Rats; Rats, Wistar; Signal Transduction | 2018 |
[Protective effect of valsartan or/and ligustrazine on hippocampal neuronal loss in rats with vascular dementia].
Topics: Animals; Dementia, Vascular; Drug Synergism; Hippocampus; Male; Maze Learning; Memory; Neurons; Neuroprotective Agents; Pyrazines; Random Allocation; Rats; Rats, Sprague-Dawley; Tetrazoles; Valine; Valsartan | 2011 |